LC
IDXX icon

Luminist Capital’s Idexx Laboratories IDXX Stock Holding History

Luminist Capital’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.6K Buy
+100
New +$56.1K 0.06% 95

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Luminist Capital's IDXX Position: Q2 2026 in Review

Luminist Capital opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 100 shares worth $52.6K. The stake represents 0.06% of the portfolio and ranks #95 among its holdings.

1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Luminist Capital held 100 shares of Idexx Laboratories worth $52.6K as of Q2 2026.
  • Idexx Laboratories was a new Luminist Capital position in Q2 2026.
  • Idexx Laboratories made up 0.06% of Luminist Capital's portfolio in Q2 2026, its #95 holding.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Luminist Capital's 13F filing for Q2 2026, filed 7 Aug 2026.